SCHEMBL5350184

SCHEMBL5350184

Cc1ccc(C2(c3ccc(C)c(OP(=O)(O)O)c3)OC(=O)c3ccccc32)cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.60
MAPT P10636 4/20 0.60
POLB P06746 3/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
NPSR1 Q6W5P4 3/20 0.48
TYMS P04818 3/20 0.48
GPR55 Q9Y2T6 2/20 0.48
TP53 P04637 2/20 0.48
CYP3A4 P08684 2/20 0.48
ALOX15 P16050 2/20 0.48
ALDH1A1 P00352 1/20 0.48
ESR1 P03372 1/20 0.48
TSHR P16473 1/20 0.48
ESR2 Q92731 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ALOX12 P18054 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860984 0.90 LMNA (0.59) LMNAMAPTPOLBMEN1KMT2A
Phosphoric Acid SCHEMBL11870420 0.87 LMNA (0.70) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL404778 0.86 LMNA (0.79) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL29614640 0.86 LMNA (0.79) LMNAMAPTPOLBMEN1KMT2A
Meglumine SCHEMBL8603121 0.85 LMNA (0.45) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL6676502 0.85 LMNA (0.74) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL8407054 0.84 LMNA (0.72) LMNAMAPTPOLBMEN1KMT2A
Phosphoric Acid SCHEMBL5350179 0.79 LMNA (0.90) LMNAMAPTPOLBMEN1KMT2A
Phosphoric Acid SCHEMBL11870423 0.78 LMNA (0.87) LMNAMAPTPOLBMEN1KMT2A
Phosphoric Acid SCHEMBL8407059 0.78 LMNA (0.87) LMNAMAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825264-B1 Stable mixture for detecting alkaline phosphatase, with a salt of o-cresolphthalein monophosphoric acid ROCHE DIAGNOSTICS GMBH (DE) 2004-10-13 EP claimed
US-5948631-A COLORIMETRIC ANALYSIS OF PHOSPHATASE ROCHE DIAGNOSTICS GMBH (DE) 1999-09-07 US claimed
US-3975405-A Monophosphate salt of o-cresolphthalein COULTER DIAGNOSTICS, INC. (US) 1976-08-17 US claimed
JP-10084992-A None JP disclosed
EP-1709186-B1 CHARCOAL STABILIZATION OF PHENYL PHOSPHATES SURMODICS IVD INC (US) 2013-04-24 EP disclosed
US-7214481-B2 Charcoal stabilization of phenyl phosphates BIOFX LABORATORIES, INC. (US) 2007-05-08 US disclosed
US-20060063220-A1 Charcoal stabilization of phenyl phosphates BIOFX LABORATORIES, INC. (US) 2006-03-23 US disclosed
US-7001717-B2 Charcoal stabilization of phenyl phosphates BIOFX LABORATORIES, INC. (US) 2006-02-21 US disclosed
US-20050124024-A1 Charcoal stabilization of phenyl phosphates BIOFX LABORATORIES, INC. (US) 2005-06-09 US disclosed
EP-0825264-B1 Stable mixture for detecting alkaline phosphatase, with a salt of o-cresolphthalein monophosphoric acid ROCHE DIAGNOSTICS GMBH (DE) 2004-10-13 EP disclosed
US-5948631-A COLORIMETRIC ANALYSIS OF PHOSPHATASE ROCHE DIAGNOSTICS GMBH (DE) 1999-09-07 US disclosed
US-5948631-A COLORIMETRIC ANALYSIS OF PHOSPHATASE ROCHE DIAGNOSTICS GMBH (DE) 1999-09-07 US disclosed
US-5948631-A COLORIMETRIC ANALYSIS OF PHOSPHATASE ROCHE DIAGNOSTICS GMBH (DE) 1999-09-07 US disclosed
JP-H1084992-A STABILIZED MIXTURE FOR DETECTING ALKALINE PHOSPHATASE CONTAINING ORTHO-CRESOLPHTHALEIN MONOPHOSPHATE BOEHRINGER MANNHEIM GMBH 1998-04-07 JP disclosed
EP-0825264-A1 Stable mixture for detecting alkaline phosphatase, with a salt of o-cresolphthalein monophosphoric acid Roche Diagnostics GmbH (DE) 1998-02-25 EP disclosed
US-4985414-A DETERMINATION OF PHOSPHATASE ENZYME BOEHRINGER MANNHEIM GMBH (DE) 1991-01-15 US disclosed
US-3975405-A Monophosphate salt of o-cresolphthalein COULTER DIAGNOSTICS, INC. (US) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124024-A1 Charcoal stabilization of phenyl phosphates PNP, ALPP, PRCP LMNA 3210/4885MAPT 3943/4885POLB 1635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.